Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

ArthroCare Slips To Loss On One-time Charges - Quick Facts

Surgical products company ArthroCare Corp. (ARTC: Quote) Thursday reported fourth-quarter net loss to common shares of $29.3 million or $1.06 per share, compared to net income of $10 million or $0.30 per share last year.

Analysts polled by Thomson Reuters expected earnings of $0.20 per share for the quarter. Analysts' estimates typically exclude special items.

Results for the quarter included a charge of $74 million for the proposed settlement of securities class actions, partly offset by proceeds of $7.8 million to settle the derivative actions.

Revenue for the quarter slightly fell to $92.4 million from $92.6 million a year ago. Analysts expected revenues of $97.47 million.

Click here to receive FREE breaking news email alerts for ArthroCare Corp. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Computer and printer maker Hewlett-Packard Co. said Tuesday after the markets closed that its fourth quarter profit fell 6% from last year, as revenue declined 2%. The company's quarterly earnings per share, excluding items, came in line with analysts' expectations, but its quarterly revenue fell short of analysts' forecast. This organic and natural products company has experienced strong compounded annual growth over the last four fiscal years with its net sales growing 25% and adjusted income from continuing operations over 30%. Here is a quick summary of the earnings reported after the bell on Nov. 24. 1. Amira Nature Foods Ltd (ANFI) reported net income for the second quarter of $8.3 million or $0.29 per share, compared to $5.0 million or $0.18 per share for the year-ago quarter. Excluding items, adjusted earnings...
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.